3be9
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
| - | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/be/3be9_consurf.spt"</scriptWhenChecked> | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/be/3be9_consurf.spt"</scriptWhenChecked> |
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
Revision as of 06:30, 4 April 2018
Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities
| |||||||||||
Categories: Maize | Non-specific serine/threonine protein kinase | Almassy, R | Averill, A | Chu, S | Erickson, P | Lu, J | Margosiak, S | Nie, Z | Perretta, C | Atp-binding | Casein kinase ii | Enzyme-inhibitor complex | Nucleotide-binding | Protein kinase ck2 | Serine/threonine-protein kinase | Structure-based drug design | Transferase
